Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT07195175
PHASE1
Study of MAR002 in Healthy Men
Sponsor: Marea Therapeutics
View on ClinicalTrials.gov
Summary
Evaluate the safety and tolerability of subcutaneous (SC) administration of MAR002 in healthy men
Official title: First in Human, Randomized, Blinded, Placebo-Controlled Single Ascending Dose and Multiple Dose Study of MAR002 in Healthy Men
Key Details
Gender
MALE
Age Range
18 Years - 40 Years
Study Type
INTERVENTIONAL
Enrollment
45
Start Date
2025-08-11
Completion Date
2026-07
Last Updated
2026-01-12
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
MAR002
subcutaneous injection
DRUG
Placebo
Subcutaneous injection
Locations (1)
Marea Site
Tempe, Arizona, United States